Quantcast

Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...




Untitled Document

Aphria, Inc. (APHQF)

Aphria, Inc. is one of Canada's lowest cost producers that produces, supplies, and sells medical cannabis. Listed on the OTC Markets Group's OTCQB, the company works to provide pharmaceutical-grade medical cannabis, and first-rate patient care. Its dedication is to doing this while balancing patient economics and returns to shareholders. Aphria has its corporate headquarters in Leamington, Ontario.

The company's medical cannabis products are 100 percent greenhouse grown. Aphria's commitment is to ensuring patients receive consistent, safe, and effective medical cannabis products.

Aphria is a Health Canada Licensed Producer of medical cannabis products. The only legal access to medical cannabis in Canada is through Health Canada Licensed Producers. However, some Canadians still have personal production licenses. This grants them authorization to produce medical cannabis for personal use.

Aphria was the Canadian Cannabis Award Winner for Best Customer Service 2016. It was also ranked Number 1 in Patient Care for 2016.

The company's cannabis oil products are produced using C02 extraction methods. These methods preserve purity and ensure safety. Aphria's equivalency factor of cannabis oil to dried cannabis is 6:1. Therefore, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis. Frequently, an appropriate dose for new patients using THC cannabis oil is 0.5-1.5mL.

Patients are always registered within 48 hours. Patients may order the amount of cannabis oil, which is equivalent to the amount of dried cannabis prescribed on their medical document.

Recently, Aphria announced that its Board of Directors approved a $137 million capital project, known internally as Part IV expansion. The project will increase the company's capacity under the Access to Cannabis for Medical Purposes Regulations (ACMPR) from 300,000 square feet to 1,000,000 square feet.

Further to the 1,000,000-greenhouse growing square feet, Aphria's infrastructure will increase to more than 250,000 square feet, necessary to service the anticipated 70,000 kilograms of eventual annualized harvests. The company is amid completing its earlier disclosed 57,000 square foot Part II expansion, and also its 200,000-square foot Part III expansion.

 

 

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue